Sanofi SA (NASDAQ:SNY)

52.15
BATS BZX Real-Time Price
As of 11:45am ET
 +0.22 / +0.42%
Today’s Change
44.76
Today|||52-Week Range
55.00
+7.33%
Year-to-Date
Is Sanofi a Good Buy in 2021?
6:20am / MotleyFool.com - Paid Partner Content
Could AstraZeneca and Sanofi Win Big in RSV?
May 08 / MotleyFool.com - Paid Partner Content
Covenant Partners, LLC Buys JPMorgan Chase, U.S. ...
2:38am / GuruFocus News - Paid Partner Content
Regeneron (REGN) Q1 Earnings Beat on Strong Eylea & Dupixent
May 06 / Zacks.com - Paid Partner Content
Novavax's (NVAX) Q1 Loss Widens, Revenues Beat, Shares Down
May 11 / Zacks.com - Paid Partner Content
Why Regeneron's Q1 Results Looked Great Despite Its Revenue Miss
May 06 / MotleyFool.com - Paid Partner Content
Amicus' (FOLD) Q1 Loss Wider Than Expected, Sales Up Y/Y
May 11 / Zacks.com - Paid Partner Content
Global Blood's (GBT) Q1 Earnings Miss, Revenues Rise Y/Y
May 06 / Zacks.com - Paid Partner Content
Biden's Budget May Boost These 3 Biotechs
May 10 / MotleyFool.com - Paid Partner Content
Novo Nordisk's (NVO) Q1 Earnings and Sales Beat Estimates
May 05 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close51.93
Today’s open51.72
Day’s range51.72 - 52.20
Volume16,411
Average volume (3 months)2,243,402
Market cap$129.6B
Data as of 11:45am ET, 05/12/2021

Growth & Valuation

Earnings growth (last year)+330.16%
Earnings growth (this year)+6.40%
Earnings growth (next 5 years)+6.82%
Revenue growth (last year)+1.61%
P/E ratio8.8
Price/Sales2.98
Price/Book1.68

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+1.34+1.75%
AZNAstraZeneca+0.82+1.52%
BMYBristol-Myers Squibb+0.70+1.09%
GSKGlaxoSmithKline+0.41+1.07%
Data as of 11:45am ET, 05/12/2021

Financials

Last reporting date--
EPS forecast (this quarter)$0.70
Annual revenue (last year)$41.1B
Annual profit (last year)$14.0B
Net profit margin34.17%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Paris, Ile-de-france

Forecasts